Wall Street Breakfast
Australia bans weight loss drug copycats
Wed, 22 May
From Default Workspace • No contributors
The health ministry cites adverse effects linked to compound versions. (0:16) Target falls on guidance. (2:44) The real AI boom darling (not Nvidia). (5:02)Show NotesBuzzFeed stock surges as Vivek Ramaswamy discloses 7.7% stakeHybrid vehicle registrations outpace battery-electric vehicles in Europe againEpisode transcripts seekingalpha.com/wsbSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
No persons identified in this episode.
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster